• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

32
28
26
26
24

COUNTRY

10
6
6
5
5

CATEGORIES

  • 40
  • 21
  • 14
  • 9
  • 9
  • 8
  • 8
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
SHOW ALL…

PRICE

26
30
33
98

PUBLISHED

1
2
13
98

PRODUCT TYPE

55
26
14
1
1
1

Search "Proteomics of the Nervous System" returned 98 results.

PRODUCT TITLE
Proteomics - Technologies, Markets and Companies Proteomics - Technologies, Markets and Companies - Product Thumbnail Image

Proteomics - Technologies, Markets and Companies

This report describes and evaluates the proteomic technologies that will play an important role in drug discovery, molecular diagnostics and practice of medicine in the post-genomic era - the first...

June 2015
FROM
Central Nervous System Partnering Terms and Agreements Central Nervous System Partnering Terms and Agreements - Product Thumbnail Image

Central Nervous System Partnering Terms and Agreements

The Central Nervous System Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the central nervous system partnering deals and agreements entered...

August 2014
FROM
Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies - Product Thumbnail Image

Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies

The delivery of drugs to central nervous system (CNS) is a challenge in the treatment of neurological disorders. Drugs may be administered directly into the CNS or administered systematically (e.g.,...

June 2015
FROM
Biomarkers - Technologies, Markets and Companies Biomarkers - Technologies, Markets and Companies - Product Thumbnail Image

Biomarkers - Technologies, Markets and Companies

This report follows the broad definition of a biomarker as a characteristic that can be objectively measured and evaluated as an indicator of normal biological or pathogenic processes as well as pharmacological...

June 2015
FROM
Biomarkers - Global Strategic Business Report Biomarkers - Global Strategic Business Report - Product Thumbnail Image

Biomarkers - Global Strategic Business Report

This report analyzes the worldwide markets for Biomarkers in US$ Million by the following Technologies and Services: Technologies - Emerging Biomarker Technologies (Imaging biomarkers, Proteomics, Transcriptomics,...

August 2011
FROM
Molecular Diagnostics - Technologies, Markets and Companies Molecular Diagnostics - Technologies, Markets and Companies - Product Thumbnail Image

Molecular Diagnostics - Technologies, Markets and Companies

This report describes and evaluates the molecular diagnostics technologies that will play an important role in practice of medicine, public health, pharmaceutical industry, forensics and biological...

June 2015
FROM
Cytogenetics - Technologies, Markets and Companies Cytogenetics - Technologies, Markets and Companies - Product Thumbnail Image

Cytogenetics - Technologies, Markets and Companies

This report deals with cytogenetics in a broader sense rather than the classical use mainly to describe the chromosome structure and identify abnormalities related to disease. In the age of molecular...

June 2015
FROM
Nitric Oxide - Therapeutics, Markets and Companies Nitric Oxide - Therapeutics, Markets and Companies - Product Thumbnail Image

Nitric Oxide - Therapeutics, Markets and Companies

This report describes the latest concepts of the role of nitric oxide (NO) in health and disease as a basis for therapeutics and development of new drugs. Major segments of the market for nitric oxide-based...

June 2015
FROM
Alzheimer Disease - New Drugs, Markets and Companies Alzheimer Disease - New Drugs, Markets and Companies - Product Thumbnail Image

Alzheimer Disease - New Drugs, Markets and Companies

Alzheimer's disease remains a challenge in management. With nearly 8 million sufferers from this condition in the seven major markets of the world and anticipated increases in the future. Considerable...

June 2015
FROM
Neuroprotection - Drugs, Markets and Companies Neuroprotection - Drugs, Markets and Companies - Product Thumbnail Image

Neuroprotection - Drugs, Markets and Companies

This report describes the role of neuroprotection in acute disorders such as stroke and injuries of the nervous system as well as in chronic diseases such as neurodegenerative disorders because many...

June 2015
FROM
Cell Therapy - Technologies, Markets and Companies Cell Therapy - Technologies, Markets and Companies - Product Thumbnail Image

Cell Therapy - Technologies, Markets and Companies

This report describes and evaluates cell therapy technologies and methods, which have already started to play an important role in the practice of medicine. Hematopoietic stem cell transplantation is...

June 2015
FROM
Companion Diagnostics Partnering Terms & Agreements Companion Diagnostics Partnering Terms & Agreements - Product Thumbnail Image

Companion Diagnostics Partnering Terms & Agreements

The Companion Diagnostics Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the companion diagnostics partnering deals and agreements entered into...

November 2014
FROM

Neural Degeneration and Repair. Gene Expression Profiling, Proteomics and Systems Biology

With contributions from leading scientists around the world, this is the first book focussing on the analysis of nerve cell damage and repair using genomics, transcriptomics, proteomics and systems...

February 2008
09 - 2012 Emerging Medical Technologies Spotlight: A Report of Investment & Partnering Opportunities 09 - 2012 Emerging Medical Technologies Spotlight: A Report of Investment & Partnering Opportunities - Product Thumbnail Image

09 - 2012 Emerging Medical Technologies Spotlight: A Report of Investment & Partnering Opportunities

This report includes details on 30 emerging medical technology companies that have been identified by LSI's in-house research team in September 2012. All companies include technology, market(s), key...

September 2012
FROM
Antiviral Therapeutics - Technologies, Markets and Companies Antiviral Therapeutics - Technologies, Markets and Companies - Product Thumbnail Image

Antiviral Therapeutics - Technologies, Markets and Companies

This report reviews the current state-of-art of antiviral approaches including vaccines, pharmaceuticals and innovative technologies for delivery of therapeutics. The introduction starts with a practical...

June 2015
FROM
European Biomarker Analysis Market European Biomarker Analysis Market - Product Thumbnail Image

European Biomarker Analysis Market

This research service gives a detailed analysis of the biomarker analysis market in Europe from 2005-2015 This Frost & Sullivan research service titled European Biomarker Analysis Market provides revenue...

September 2009
FROM
03 - 2013 Emerging Medical Technologies Report 03 - 2013 Emerging Medical Technologies Report - Product Thumbnail Image

03 - 2013 Emerging Medical Technologies Report

This report includes details on 30 emerging medical technology companies that have been identified by in-house research team in March 2013 All companies include technology, market(s), key executive,...

March 2013
FROM

Developmental Genomics of Ascidians

The simplicity and lack of redundancy in their regulatory genes have made ascidians one of the most useful species in studying developmental genomics. In Developmental Genomics of Ascidians, Dr. Noriyuki...

January 2014

DNA Microarray 2013: A Focus on Sales Growth

Summary: This market analysis was carried out to provide business information to developers, manufacturers and suppliers in the DNA microarray field Its findings include: - Marketing and sales opportunities...

February 2013
FROM
Pharmacogenomics Partnering Terms and Agreements Pharmacogenomics Partnering Terms and Agreements - Product Thumbnail Image

Pharmacogenomics Partnering Terms and Agreements

The Pharmacogenomics Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the pharmacogenomics partnering deals and agreements entered into by the...

November 2014
FROM
Loading Indicator

Our Clients

Glanbia Plc. Unilever N.V. Microsoft Corporation Duke University A.T. Kearney PepsiCo Inc. Boston Consulting Group